Bio City chooses $200m pre-IPO convertible
ISM Capital delivered a $200m pre-IPO convertible for Bio City Development, an Istanbul and Dubai-based healthcare infrastructure development firm, this week and expects to exercise a $25m greenshoe in the coming weeks.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts